Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

10 treatments under study, led by Antidepressant

Research Leaders

12 sponsors active, led by Family and Medical Counseling Service, Inc

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Phase 2 (2)

Trial Status

Completed1
Unknown1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT04747314Phase 2Completed

Treating Negative Affect in Low Back Pain Patients

NCT06980090Not ApplicableRecruitingPrimary

Neural Mechanisms of Interpersonal Expectations on Negative Affect

NCT04850664Phase 2Unknown

Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder

Showing all 3 trials

Research Network

Common Treatments

  • Antidepressant1
  • Session B Positive Placebo Sham Ttis1
  • Session C Negative Placebo Active Ttis1
  • Session A Positive Placebo Active Ttis1
  • Session E Onplacebo Sham Ttis1

Active Sponsors

  • Family and Medical Counseling Service, Inc1
  • Clinics of Dr. Edwin Chapman, MD, PC @ MHDG1
  • Massachusetts General Hospital1
  • Mayo Clinic1
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1

Top Investigators

Related Conditions

  • Expectations1
  • Chronic Low Back Pain1
  • Placebo Effect1
  • Withdrawal Symptoms1
  • Noninvasive Brain Stimulation1

Activity Timeline